<DOC>
	<DOCNO>NCT01509248</DOCNO>
	<brief_summary>1 . Population pharmacokinetics : The purpose study - investigate population pharmacokinetics theophylline premature Korean infant assess influence demographic clinical covariates . 2 . Metabolomics : The purpose study - predict serum theophylline level ass CYP1A2 activity premature infant analyze urinary metabolite theophylline - examine factor affect clearance theophylline CYP1A2 activity premature infant</brief_summary>
	<brief_title>Population Pharmacokinetics Metabolomics Theophylline Preterm Infants</brief_title>
	<detailed_description />
	<mesh_term>Premature Birth</mesh_term>
	<mesh_term>Theophylline</mesh_term>
	<criteria>Inborn preterm infant ( GA &lt; 37 week ) Dx : Apnea prematurity Tx : Aminophylline / Theophylline Informed consent parent Major congenital anomaly Expired within 72 hour Proven secondary apnea</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>37 Weeks</maximum_age>
	<verification_date>February 2012</verification_date>
	<keyword>Theophylline</keyword>
</DOC>